Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (0704-0188), Washington, DC 20503
INTRODUCTION
Gulf War (GW) veterans continue to complain of short-term memory and mood problems many years following their return from the Persian Gulf. Research to date suggests that it is unlikely that there is one single cause for GW illness but rather suggests that multiple causes in different groups of veterans is the likely the cause of continued health symptoms. Suspected causes for GW veterans continued health complaints include additive and/or synergystic effects of the varying combinations of exposures to pesticides, pyridostigmine bromide (PB), low-level nerve agents, and psychological trauma. Research evaluating the effects of pyridostigmine bromide (PB) exposure on neuropsychological functioning in GW veterans, found significantly lower performance on tasks assessing executive system functioning in the PB exposed GW veterans compared with controls (Sullivan et al., 2003) . Pesticide exposure has been associated with mood decrements and residual effects many years after exposure in a large longitudinal cohort of GW veterans (White et al., 2001 ). In addition, low-level nerve agent exposure (from Khamisiyah weapons arsenal) has been associated with mood complaints and executive system decrements in GW veterans (White et al., 2001) .
It has been documented that many pesticides are neurotoxicants as are PB and nerve agents. Two subsets of these chemicals, organophosphates (OP) and carbamates, are known to produce chronic neurological symptoms at sufficient exposure levels. For example, recent studies of agricultural workers and professional pesticide applicators have found lasting deficits in neurological and cognitive functioning resulting in decreased processing speed and mood complaints (Stephens et al., 1995; Steenland et al., 1994) .
It is the goal of this study to further evaluate the role of pesticides in the development of CNS symptoms reported by GW veterans and to assess the additive and!or synergistic effects of combinations of chemical exposures and stress. This will be accomplished by assessing a group of military pesticide applicators with known chemical exposures. It is hypothesized that applicators with high exposures will perform significantly worse on specific cognitive and neurological measures and report more health symptom complaints than a group of GW military personnel with very little pesticide exposure. It is also hypothesized that multiple chemical exposures (PB, pesticides, low-level nerve agents) will be synergistic and/or additive in terms of decreased cognitive and neurological functioning.
The specific aims of this study are: (1) To determine the cognitive and neurological effects of pesticide exposure in specific groups of GW veterans (2) To determine the cognitive and neurological effects of PB exposure in specific groups of pesticide exposed GW veterans (3) To assess for interaction effects in GW veterans with multiple chemical exposures (PB, pesticides, low-level nerve agents).
Body
The approved statement of work for the entire study period is below:
STATEMENT OF WORK Neuropsychological Functioning in Gulf War Veterans Exposed to Pesticides and Pyridostigmine Bromide. SRBI, an independent contracting company (with an 80% success rate) will contact all PCIs and obtain current address and administer a brief follow-up questionnaire (months 3-4). c.
Categorize PCIs into high and low exposure groups for pesticides and pyridostigmine bromide (PB) exposure (months 3-5). d.
Identify pool of potential subjects for each of four exposure categories to recruit (months 4-5). e.
Screen potential subjects for exclusion criteria (months 5-6). Interim Statistical analyses of data obtained from cognitive evaluations and questionnaire data will be performed periodically (months 18-42). c.
Exposure assessment analyses for pesticides and PB will be ongoing (months 18-42). d.
Annual reports of progress will be written Center (a joint program of the VA Boston Healthcare System and Boston University).
The MOU states:
1) The released PCI records will only be used for the purposes of the current study 2) Only study personnel will have access to the released records
3) The released information will be safeguard to preserve the confidentiality of the data 4) Any personal identifiers will be removed from any interim and final reports that are prepared as a consequence of this study.
The PCI interview records were used in conjunction with current interview data to categorize individuals into high and low pesticide and PB (pyridostigmine bromide) exposure categories. In addition, these interviews will also be used in conjunction with the current exposure questionnaires to perform dose-estimates for pesticides and PB. Mr. William Bradford, lead author of the Pesticides Environmental Exposure Report, will be available to assist with these dose-estimates in years 2-4.
Task 1 b. SRBI, an independent contracting company will contact PCIs and obtain current address and administer a brief follow-up questionnaire.
An outside research firm (Schulman, Ronca, & Bucuvalas, Inc., SRBI) with extensive experience collecting data from veterans of the U.S. Armed Forces was subcontracted to obtain current telephone numbers and addresses for the PCIs and to administer a brief follow-up questionnaire by telephone. The recruitment process was as follows: PCIs were sent a letter from the PI explaining that SRBI would be contacting them to conduct a brief telephone interview and obtain their current contact information for the study. A postage paid opt-out postcard was included with this introduction letter. If the PCI elected to return this postcard, there was no further contact with this individual for the study. If a postcard was not returned to the study staff, SRBI attempted to contact the PCI and determine if they wished to participate in the brief interview regarding their pesticide and PB exposures during the Gulf War. Ten individuals returned the opt-out postcards and were not contacted further for this study. From the remaining list, SRBI was successful in completing 160 telephone interviews with PCIs regarding neurotoxicant exposures resulting in a live refusal rate of just seven percent. SRBI was also able to find current contact information for all 293 PCIs and identify that one PCI was deceased.
The study design is presented in the figure below followed by tables of demographic information computed from the SRBI telephone interview data.
Figure 1. Pesticide Study Assessment Design
From the SRBI telephone interviews, demographic and exposure data was collected from each responding PCI. The demographic information is reported in table 1. From this group of 160 study respondents, 140 were male and 20 were female. The average age for the group of Gulf War veterans was 48 years old and the group was largely Caucasian (85%). The most commonly reported current health problems reported by these study participants were hypertension, cardiovascular disease, arthritis, asthma, back and joint pain, skin rash and memory problems.
When broken down into groups based on high and low groups for pesticides and PB, the only notable differences were found in increased reporting of hypertension (12 vs. 6 PCIs), cardiovascular disease (6 vs. 2 PCIs) and arthritis (6 vs. I PCI) in the high pesticide group compared with the low pesticide group. While the high and low PB groups did not appear to differ very much with respect to health symptom reporting from this brief health query included in the telephone interviews. The larger study questionnaire with more in-depth questions regarding medical diagnoses will help to better characterize these groups in terms of health outcomes and show their significance. The demographic breakdown of the SRBI surveys is reported in table 1. Task 1 c. Categorize PCIs into high and low exposure groups for pesticides and pyridostigmine bromide (PB) exposure.
Pesticides were used widely in the Gulf War to protect troops from such pests as sand flies, mosquitoes and fleas that can carry the infectious diseases leishmaniasis, sand fly fever and malaria. Indeed, of the nearly 700,000 US troops deployed to the Gulf region, only 40 cases of infectious diseases were documented (Winkenwerder Jr, W., 2003) . US forces used pesticides in areas where they worked, slept, and ate throughout the GW. In fact, on any given day during their deployment, GW veterans could have been exposed to 15 pesticide products with 12 different active ingredients and pesticide applicators were likely exposed to more pesticide products and at higher doses. Troops used pesticides for a number of reasons, including personal use on the skin and uniforms as an insect repellent, as area sprays and fogs to kill flying insects, in pest strips and fly baits to attract and kill flying insects, and as delousing agents applied to enemy prisoners of war. These widespread, commonly reported uses supported the decision by the OSAGWI to investigate pesticide exposures as a potential contributor to unexplained illnesses in GW veterans.
According to the OSAGWI report, the pesticides of potential concern (POPCs) used by US military personnel during the GW can be divided into five major classes or categories:
1) organophosphorus pesticides, such as malathion and chlorpyrifos; 2) carbamate pesticides, such as bendiocarb; 3) the organochlorine, lindane; 4) pyrethroid pesticides, such as permethrin;
and 5) the insect repellent DEET (see figures 2 through 4). Fgr4.Aplcatore exposredlevels rechingtevlsofcncernMO 15siidso poeta cocreng, PhD06KSlianhD
Guidelines for pesticide and PB exposure are presented in the tables 2 and 3 and were used to classify participants into high and low exposure categories based on prior OSAGWI interviews and current interviews conducted by SRBI. Table 2 . Guidelines for Pesticides
Low exposure An individual is assigned to the low-exposure category for pesticides if he or she does not fit the guidelines for high exposure, as described below. For example, an individual exposed to pyrethroids other than via fogs, but no other pesticides, would be assigned to a low pesticide exposure group.
High exposure An individual is assigned to the high-exposure category for pesticides if any of the following apply:
1) PCI reported experiencing acute signs and/or symptoms of pesticide overexposure, other than minor skin irritation, at least once. A general statement, such as "became ill" will qualify.
2) PCI probably applied pesticides from any of the following groups on two or more occasions: organophosphate (OP) emulsifiable concentrate (EC) or ultra low volume (ULV) products, carbamate ECs. or powders, lindane used for enemy prisoners of war (EPWs), fly baits (>2 pounds handled), and/or fogs. PCI may or may not have worn adequate personal protective equipment (PPE).
3) PCI was probably present during applications of OP ECs/ULVs, carbamate ECs/powders, DDT, and/or fogs on two or more occasions. 4) PCI probably spent at least 1 week living/working in structures treated inside with OP and/or carbamate ECs, ULVs, powders, DDT, and/or pest strips, and likely experienced substantial post-application exposure. 5) PCI probably applied DEET to self at least 30 times. PCI must provide enough information to conclude that usage was equivalent to or above this level. DEET application 30 times per month is the 25th percentile value determined by the RAND (2000) survey for ground forces who used DEET (50% reported no use). Table 3 . Guidelines for PB Low exposure An individual is assigned to the low-exposure category for PB if no acute signs and/or symptoms of exposure were reported and any of the following apply:
1) The individual reported not using PB.
2) The total dose reported was less than or equal to 180 mg PB active ingredient.
3) The individual reported using PB, but could not recall sufficient details to conclude that the dose was probably greater than 180 mg PB active ingredient.
High exposure Individuals are assigned to the high-exposure category for PB if either of the following apply:
1) The total dose was probably greater than 180 mg PB active ingredient.
2) The individual reported taking any PB and also reported experiencing acute signs and/or symptoms of exposure.
PB and pesticide exposure were categorized as high and low based on the previous OSAGWI interviews and the current SRBI interviews. From these interviews, 97 PCIs were categorized in the high pesticide exposure group and 63 PCIs were categorized in the low pesticide exposure group and 81 PCIs were categorized in the high PB group and 79 PCIs were categorized in the low PB group. Additional categorization for pesticide and PB exposure and Khamisiyah notification (identifying those potentially exposed to chemical weapons) are listed in table 4. Task 1 e. Screen potential subjects for exclusion criteria.
The exclusion criteria for this study include current substance abuse, substantial traumatic brain injury or other documented neurological illness precluding the use of a computer. Prior substance abuse and current medications are recorded but do not constitute exclusion criteria.
These exclusion criteria were chosen so that study participants who may perform poorly on cognitive testing for known reasons other than environmental exposures could be screened out to prevent potential study confounders.
From the SRBI telephone interviews, a review of reported health symptoms was performed and no participant from these interviews reported significant head injury or other significant neurological illness that might interfere with performing the cognitive and computer testing parts of the study protocol. There was one case reported of a brain tumor recently removed and a case of multiple sclerosis (MS). However, the study participant with MS was one of the first recruited study participants for the cognitive evaluations and was able to complete the entire study protocol. In the first recruitment trip, none of the study participants were screened out.
Subject recruitment is ongoing and PCIs consenting to participate are asked questions to determine whether they meet preliminary inclusion criteria for the study (that is, that they participated in the OSAGWI interviews (1997-1998), are not currently in treatment for substance abuse, do not have sensory or motor impairments precluding use of the computer, and did not sustain a serious brain injury. Screening for exclusion criteria occurs during the telephone recruitment phase of the study and will be ongoing during the study recruitment efforts.
Task 2a. Recruitment of 20 study subjects and arrange for travel to multiple study sites.
Twelve study participants were recruited and have completed the study protocol The current address for each PCI was obtained by SRBI during their telephone interviews and the breakdown by state is listed in Table 6 . This information will enable better planning for recruitment trips to these locations. The recruitment strategy will be to target the more populated areas first. The next planned recruitment trips will be in Florida followed by Virginia and Maryland. It is anticipated that the recruitment of 58 additional study participants (50 projected for Year 2 plus 8 from Year 1 projections) will be obtainable by the end of Year 2 for a total of 70 recruited study participants. Given the favorable response from the first recruitment efforts, major difficulties with subject recruitment are not anticipated at this time. 
Recruitment Methodology
When recruiting study participants, the PI or study staff contact PCIs participating in the SRBI interviews to describe the study and establish whether the PCI will participate in the cognitive evaluation. The initial contact with the study staff consists of a description of the study, describing the types of assessment, time required, and reimbursement for their time and effort. Subjects have an opportunity to ask questions about the procedure. They are informed that whether or not they participate will have no bearing on their medical care and that, if they choose to participate, they may withdraw at any time without prejudice. They are asked to indicate whether they wish to participate, wish not to participate, or wish to defer this decision. In the latter case they are asked whether we may contact them again to determine their decision. Gulf War veterans who are currently on active duty are contacted at home in the evening hours and will not be contacted during duty hours. Active duty PCIs are not be compensated for their participation as there are restrictions on compensation to active duty personnel. PCIs consenting to participate are asked questions to determine whether they meet preliminary inclusion criteria for the study (that is, that they participated in the OSAGWI interviews (1997-1998), are not currently in treatment for alcohol or other substance abuse, do not have sensory or motor impairments precluding use of the computer, and did not sustain serious brain injury). Prior substance abuse and current medications are recorded but do not constitute exclusion criteria. An appointment during one of the field trips is scheduled for subjects agreeing to participate. PCI veterans retained in the study sample are presented the study consent form for signature. The study methodology is presented in figure 5 . 
Task 2b. Perform cognitive evaluations and psychodiagnostic interviews with 20 participants
The goal for year 1 was to recruit and perform cognitive and psychodiagnostic interviews with 20 study participants. As described above, a total of 12 study participants were recruited in year I due to a slow start-up phase for the study. However, all twelve of the study participants completed the entire study protocol and did not express any difficulties with the length of the examination. The cognitive evaluations were completed in 1.5 hours for most of the study participants and the psychodiagnostic interviews required an additional twenty minutes in most cases to complete. Study participants are able to take breaks during the study protocol session if they feel they need them and can fill out their questionnaires and mail them back if necessary. With this strategy, it is not anticipated that there will be much missing data from the study protocols. However when missing data is encountered during data analysis, interpretative statistics will be employed whenever possible.
A description of the neuropsychological domains and the complete neuropsychological test battery are presented in the tables 7 and 8 followed by a description of the study instruments and procedures. Wechsler, 1997) to assess native intellectual abilities Information subtest Boston Naming Test Confrontation naming of line drawings; Raw Score (BNT; Kaplan et al., 1983) to assess verbal abilities
I. Tests of Attention, Vigilance and tracking
Trail-making Test Timed connect-a-dot task to assess Completion (Reitan &Wolfson, 1985) attention Previous studies of occupational pesticide exposure have documented changes in reaction time and motor speed (NCTB). Therefore, we predict decreased CPT reaction time performance in the highexposed PCI group and motor slowing on the additional measures.
The test battery also includes the Profile of Mood states as a self-report assessment of current mood. The indicators of importance are current fatigue, confusion, tension and depression.
Mood has been shown to be associated with changes in subcortical-limbic system and neurotransmitters as a result of toxicant exposures and as such, mood will be treated as an outcome measure rather than as strictly a potential confounding variable.
In order to assess visuospatial processing, we will administer the Rey-Osterrieth Complex Figure Test and document total scores for the copying subtest (rey-osterrieth scoring out of 36).
We expect that individuals with increased exposures will have difficulty maintaining the overall configuration, tremulous writing and segmentation as a result of basal ganglia dysfunction commonly seen in these people. In addition, the Stanford Binet copying task will be used in this test battery to document further impairment in visuoconstruction as has been found in our prior research. The total score for copying (out of 16 possible) is expected to be diminished in those who have significant neurotoxicant exposures.
Individuals who have documented exposures to neurotoxicants have had difficulty in the areas of acquisition and retrieval. Therefore, we will be examining verbal and nonverbal memory with the use of the Rey-Osterrieth Complex Figure Immediate and Delayed recall and the CVLT-II measures of total recall trials 1 to 5 (raw score) and Long-delay free recall (raw Score).
Lastly, a measure to response consistency will be used to document the possibility of diminishment in motivation. Raw scores (out of a possible score of 50) will be computed and we expect that only a few individuals will fall below a score of 45 (indicating decreased motivation).
In the event of decreased motivation scores on this test, analyses will be performed with and without these individual's test scores to assess for potential differences. If there are significant differences between the groups, then the group with low motivational scores will be removed from the dataset.
Because this study compares neuropsychological functioning in pesticide exposed individuals many years after their GW exposures, the question arises how does one decide if decreased performance in cognitive functioning is actually associated with pesticide exposure or if those individuals with cognitive deficits simply report more pesticide exposure.
One way to examine this problem with self-reported exposures and correlating them with current brain functioning is by comparing patterns of cognitive performance in relation to the reported exposure. The field of behavioral neurotoxicology is an established field that studies the effect of brain/behavior (test performance) relationships and specific types of neurotoxicant exposures.
Epidemiological studies during the past 30 years have examined the impact of exposure to metals (e.g., lead, mercury, arsenic), organic solvents (e.g., trichloroethylene, nhexane, petroleum distillates), and pesticides (e.g., organophosphates, carbamates) on brain functioning and found different cognitive patterns with these exposures. For example, studies of solvent exposure have reliably shown disturbances in executive function, attention, visuospatial skills, short-term memory, and mood (Anger, 1990 and Echeverria& White, 1992) Studies of lead-exposed workers have yielded similar findings along with decrements in verbal reasoning and motor functions (Baker et al., 1984 , Hanninen et al., 1978 and Yokoyama et al., 1988 . While studies of pesticide-exposed agricultural workers have shown disturbances in processing speed and mood and sequelae from overt poisoning from organophosphate pesticides can result in lasting deficits in the domains of visuomotor, attention/executive functioning, motor functioning and mood. Therefore, we would be comparing not only specific test performance to self-report of pesticide exposure but also the pattern of cognitive performance in the domains of attention/executive functioning, memory, visuospatial skills, motor skills and mood.
In addition to exposure class, other factors (e.g., age, education, intelligence, prior exposures, medical and health concerns, alcohol abuse, life stress, and workplace stress) are likely to influence performance on cognitive tests (Grasso et al., 1984 , Hanninen, 1988 , Proctor et al, 1996 and Letz, 1993 and must be taken into account in evaluating the effects of exposure to known or suspected toxicants. Therefore, the study was designed to be able to compare cognitive patterns on five different domains in individuals reporting higher and lower pesticide exposures (table 7) .
We have made specific hypotheses of how the higher pesticide exposed individuals will perform based on prior epidemiological studies showing the cognitive pattern of motor (performance speed) and mood decrements in pesticide exposed individuals. We have also included a series of questionnaires to the study protocol that will obtain demographic (age, education, gender, premorbid intelligence) and diagnostic variables (Post-Traumatic Stress Disorder, Major Depression etc.) that could affect cognitive performance and should be controlled for in any analyses comparing self-reported exposures to neurotoxicants. In addition, an exposure questionnaire is also included in the study protocol (SNAC) that queries for other types of neurotoxicant exposures that could affect cognitive performance (exposures from hobbies and post-military employment) that will also be used as control variables.
2. Psychological Assessment.
1)
Subjects are administered the Structured Clinical Interview for DSM-IV (SCID) and a current Global Assessment of Functioning score is assessed. This instrument has demonstrated reliable psychometric properties for determining the presence or absence of current or past major Axis I disorders. Dr. Krengel who will also be blind to the exposure data administers the Clinician Administered PTSD Scale (CAPS), a state-of-the-art instrument for confirming the diagnosis of current or past PTSD and for evaluating the intensity, frequency, and severity of the disorder and its individual symptom criteria. Extensive research now indicates that this instrument has highly acceptable psychometric properties. Subjects fill out a series of self-report, paper and pencil measures designed to confirm and define symptoms of PTSD (PTSD checklist), and to identify traumatic events, military or civilian (Modified Life Events Checklist, Traumatic Events) (table 9) .
2) Dr. Krengel also conducts a semi-structured clinical interview eliciting information pertaining to recent past and current mood disorders, substance use, neurological and medical illness, traumatic brain injury, and history of other traumatic events. Subjects are asked questions specifically related to recent occupational history (including possible occupational exposure to neurotoxicants), family history of psychiatric disorder, and life stressors.
Treatment of Data
The aims of this study are to determine the cognitive and neurological effects of pesticide exposure in specific groups of GW veterans, to determine the cognitive and neurological effects of PB exposure in specific groups of pesticide exposed GW veterans, and to assess for interaction effects in GW veterans with multiple chemical exposures (PB, pesticides, low-level nerve agents).
We will examine the relationship between neurotoxicant exposure and neuropsychological performance through multivariate multiple regression. This will include indicator variables to account for group status (I = High PB, High Pesticide, 2 = High PB, low Pesticide, 3 = Low Pesticide, High PB, 4 = low Pesticide, Low PB) as well as individual risk factors and intervening risk factors that might be related to outcomes. Additional analyses exploring the interactions between the exposures and neuropsychological outcome will be pursued. We will look at the relationship of stress and health symptoms through the multiple regression analyses as described regarding pesticide and pyridostigmine bromide (PB) exposure were obtained and used to classify these individuals into high and low exposure groups.
> Telephone interviews were performed and resulted in only a seven percent refusal rate of live calls and completion of the targeted 160 total completed exposure surveys of PCIs.
> Potential study participants were categorized based on current residence.
> Current health symptoms were identified and categorized into symptom clusters.
> PCIs responding to the SRBI interviews were categorized into high and low exposure groups for pesticides and PB and a pool of potential subjects have been targeted for recruitment based on residence location and exposure category.
> Twelve study participants were recruited and completed the entire study protocol including cognitive evaluations, psychological interviews and exposure questionnaires.
> The first study recruitment efforts were greeted with interest and willingness to participate by the contacted PCIs. This is encouraging for further recruitment efforts.
It appears that GW veterans continue to be interested in responding to surveys regarding health symptoms and are cooperative when asked to complete neuropsychological evaluations.
>'
It was determined that the study design allows for collection of all relevant data and can be accomplished in several recruitment trips throughout the country.
CONCLUSIONS:
Preliminary findings from the current study revealed that GW veterans exposed to varying levels of pesticides and PB continue to report health symptoms, including high blood pressure, cardiovascular disease, skin rashes, memory problems and stress reactions. Of interest, veterans who participated in the SRBI telephone surveys reported significantly more physical than emotional symptoms. It is of particular clinical relevance that these veterans continue to report significant physical symptoms and by documenting changes in cognitive status in conjunction with health concerns in this unique group of Gulf War veterans, the effects of exposure to neurotoxicants while in the Gulf will be further elucidated. This study will be able to confirm or disconfirm the conclusion of the OSAGWI health risk assessment and the RAND report which suggested that the acetylcholinesterase inhibiting pesticides including organophosphates and carbamates could be among the contributing factors to some of the undiagnosed illnesses in GW veterans by performing cognitive assessments with a group of military pesticide applicators with known chemical exposures. 
